BVF »

Tenax Therapeutics shares owned by BVF

Quarter-by-quarter ownership of Tenax Therapeutics (TENX) shares owned by BVF from 13F filings

Historical chart of BVF investment in Tenax Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenax Therapeutics held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenax Therapeutics by BVF

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 340k 3.46

More positions owned by BVF

Moonlake Immunotherapeutics Class A Ord (MLTX)
Kymera Therapeutics (KYMR)
Revolution Medicines (RVMD)
Mirum Pharmaceuticals (MIRM)
Tyra Biosciences (TYRA)
Olema Pharmaceuticals (OLMA)
Structure Therapeutics Sponsored Ads (GPCR)
Cullinan Oncology (CGEM)
Xoma Royalty Corporation Com New (XOMA)
Axsome Therapeutics (AXSM)
Protagonist Therapeutics (PTGX)
4d Molecular Therapeutics In (FDMT)
Ac Immune Sa SHS (ACIU)
Gh Research Ordinary Shares (GHRS)
Kura Oncology (KURA)

View all positions for BVF

Top funds holding Tenax Therapeutics

BVF
VR Adviser
Vestal Point Capital
Stonepine Capital Management
T. Rowe Price Associates
Dimensional Fund Advisors
Geode Capital Management
Lynx1 Capital Management
Qube Research & Technologies
Tower Research Capital
BlackRock
BlackRock
Morgan Stanley
Bank of America Corporation
Hanson McClain Advisors

View all funds holding Tenax Therapeutics